Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A new strategic partnership between Fiocruz and The Global Health Network will amplify the impact of Fiocruz’s health research and capacity development initiatives by promoting research capacity building across Portuguese-speaking countries, and enabling research findings from the Zika outbreak to benefit public health worldwide.

Composite photo of the Signing of the agreement between The Global Health Network and Fiocruz - plus a group photo

Fiocruz, one of the world’s leading public health institutions and Brazil’s institute for health science and technology, has signed an agreement with The Global Health Network at the University of Oxford to enable evidence generated from research to drive improvements in global health in the most resource-poor and hard to reach areas of the globe.

This new partnership will:

  • Establish a knowledge sharing hub for Fiocruz, embedded within The Global Health Network. This hub will enhance the visibility of Fiocruz’s research and capacity development activities on this global platform. It will both connect existing partners and promote new partnerships, inviting the rest of the world to learn from and benefit from their advances. 
  • Promote research capacity building across Portuguese-speaking countries. With an initial focus on Angola, followed by Mozambique, Fiocruz and The Global Health Network will collaborate with local research organisations to promote access to training, support, tools and resources for local health works – all in Portuguese. This aims to overcome language as a barrier to conducting research, giving health workers the skills and training to build their career through research experience.
  • Share research findings and recommendations from the Zika outbreak. A knowledge sharing hub will consolidate and communicate findings from the three Zika research consortia to health workers, research teams and, most importantly, the families impacted by this devastating outbreak. It will provide a powerful mechanism for sharing the findings and helping these results get back to the community, local health delivery teams and into practice to make a lasting impact. Through sharing recommendations arising from research during the outbreak, the results can be used for public health benefit and, over time, become an integral part of vector control activities. This is an important outcome for ZikaPLAN and ZIKAction*, and for ZIKAlliance an opportunity to contribute by sharing information that can be useful for feeding the platform.

Fiocruz has a long history of embedding health research into health systems and building research capacity through equipping health workers with the skills to put research results into practice and generate evidence, with outcomes that improve the lives of their communities. The Global Health Network brings its extensive experience in knowledge sharing and communities of practice to amplify the impact of Fiocruz’s work on a global scale.

A shared ethos between Fiocruz and The Global Health Network underpins this partnership: firstly, that public health can be improved through research and, secondly, in which the advances from each programme enriches the others. By building capacity for research across the globe, evidence can be generated where such data is missing, across diseases, geographies and communities, and the impacts of this research can be accelerated when methods, best practice and experience are shared.

About The Global Health Network

More, better and faster research is critical to solving the world’s biggest health challenges. The Global Health Network is sharing knowledge, methods and tools between disease areas, regions and organisations to amplify evidence generation. Research teams and professionals are being trained and supported to lead and undertake health research in the world’s most challenging settings. This is achieved by applying the best digital technology and harnessing the sharing phenomena, working virtually and on the ground to enable the capture of life-saving data.

About Fiocruz

Fiocruz is the most prominent Institution of Science and Technology in Health in Latin America, whose mission is to produce, disseminate and share knowledge and technologies, aiming at strengthening and consolidating the Unified Health System and the promotion of health and quality of life for the population

Funding

Eu flag *This project has received funding from the European Union's Horizon 2020 Research and Innovation Programme under Grant Agreement No.s 734584, 734857.

Similar stories

Peter Horby receives prestigious award for outstanding service to public health

The Faculty of Public Health has awarded its prestigious Alwyn Smith Prize to Professor Sir Peter Horby for 2020/2021 in recognition of his outstanding service to public health as a global leader in epidemic science.

Lack of evidence is key barrier to using portable devices to detect poor quality medicines

A series of papers which reviewed portable devices to detect poor quality medicines has concluded major gaps in scientific evidence remain a key barrier for regulators to implement surveillance systems using such devices.

RECOVERY Trial paper on dexamethasone wins BMJ’s 2021 UK Research Paper of the Year Award

A RECOVERY Collaborative Group paper has been announced as the 2021 winner of The British Medical Journal’s prestigious UK Research Paper of the Year Award. This award recognises original UK research that has the potential to contribute significantly to improving health and healthcare. The paper, “Dexamethasone in Hospitalized Patients with Covid-19”, published in the New England Journal of Medicine, described the discovery in June 2020 of the world’s first effective, readily available treatment for COVID-19 – the inexpensive steroid, dexamethasone.

Tropical Medicine DPhil Students awarded NDM Prize

Every year, the Nuffield Department of Medicine awards NDM Prizes to our most outstanding students. This year, Mo yin and Rebecca Inglis (both at MORU) were highly commended in the category NDM Overall Prize, for conducting research with an outstanding impact. Will Schilling (MORU) received a prize as first year DPhil student, and Mohammad Ali (OCGHR) as second year DPhil student. Our warmest congratulations to you all!

New study alerts to the risk of poor quality medicines used to prevent and treat cardiovascular disease

There are important but neglected issues with substandard and falsified medicines and medical products used to prevent and treat cardiovascular diseases. From limited available data, MORU and IDDO scientists found about one fifth of medicines reported as sampled in the literature were substandard or falsified. This systematic review suggests that more and better quality data and data sharing are needed to better understand the global burden of this problem and inform interventions.

Systematic review identifies research gaps for Chagas disease

A new, large-scale systematic review published in PLOS Neglected Tropical Diseases has identified clear, significant research gaps in the diagnosis and treatment of Chagas disease. The paper also highlights significant differences in study design, diagnostic methods, duration of follow-up, and the timing of outcome assessment used by investigators even in the last decade.